Anti-Human IL-27 p28 eFluor® 660 (Alexa® 647 Replacement)

Also known as: Interleukin-27 subunit alpha, IL-27A, Interleukin-30

Clone: 3D1p28

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 50-8277

Cat. No. Size
50-8277-41 25 tests
50-8277-42 100 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human IL-27 p28 eFluor® 660.

Normal human peripheral blood cells unstimulated (left) or stimulated with Human IFN gamma...View More

  • Data for Anti-Human IL-27 p28 eFluor® 660.
Description

Description: This 3D1p28 monoclonal antibody reacts with the human p28 subunit of IL-27. Interleukin-27 (IL-27) is a member of the IL-12 family, a subgroup of the IL-6 family of cytokines. It is a heterodimer of the subunits EBI3 (Epstein-Barr Virus Induced Gene 3), which is homologous to the p40 subunit shared by IL-12 and IL-23, and p28 (IL-30), which is homologous to p35. IL-27 is produced by activated dendritic cells and macrophages in response to TLR ligands and inflammatory cytokines. IL-27 has been shown to have both pro-inflammatory and anti-inflammatory effects. It influences the commitment of CD4+ T-cells toward the Th1 lineage by inducing the expression of the transcription factor T-bet and the upregulation of IL-12R beta2. Its anti-inflammatory functions include the suppression of Th2 and Th17 proliferation and differentiation.

The IL-27 receptor shares one subunit, gp130, with other members of the IL-6 family. The subunit WSX-1 (IL-27R alpha, TCCR) is unique to IL-27 and is believed to be the only part of the receptor that interacts with the cytokine. IL-27R activation leads to the phosphorylation of Jak/STAT proteins, with STAT1 and STAT3 being critical to the function of IL-27.

Recent evidence suggests that the p28 subunit may also be secreted independently of EBI3 and have functions distinct from the IL-27 heterodimer: it is believed to not only antagonize the activity of IL-27, but also inhibit signaling of other gp130 ligands, such as IL-6 and IL-11.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Human
Conjugate eFluor 660
Laser Red Laser
Emit 668 nm
Excite 633 nm
Reported Applications Intracellular Staining Followed by Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Related Products
References

References: Stumhofer JS, Tait ED, Quinn WJ 3rd, Hosken N, Spudy B, Goenka R, Fielding CA, O’Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grotzinger J, Cancro MP, Levin SD, Hunter CA. A Role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat Immunol. 2010 Dec;11(12):1119-26.

Stumhofer JS and Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett. 2008 May 15; 117(2): 123-30.

Yoshimura A, Yoshida H, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura T, Takeda A, Hamano S. Two sided roles of IL- 27: induction of Th1 differentiation on Naïve CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol. 2006; 177: 5377-85.